Home > Boards > US Listed > Biotechs > Kadmon Holdings (KDMN)

KD025 just got Breakthrough Therapy Designation from the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mcp4 Member Profile
 
Followed By 0
Posts 103
Boards Moderated 0
Alias Born 03/08/08
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/6/2021 4:26:09 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/1/2021 5:08:18 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/1/2021 5:04:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2021 4:06:57 PM
FDA extends review period for Kadmon's belumosudil NDA Seeking Alpha - 3/10/2021 4:20:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/10/2021 4:17:20 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/5/2021 4:07:37 PM
Kadmon EPS misses by $0.01, beats on revenue Seeking Alpha - 3/4/2021 5:34:20 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/4/2021 4:25:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/4/2021 4:03:26 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/17/2021 3:13:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/16/2021 4:20:37 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 3:51:36 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 2:22:26 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/16/2021 11:27:14 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2021 4:43:49 PM
Kadmon stock down after pricing $200M convertible debt offering Seeking Alpha - 2/11/2021 1:04:40 PM
Kadmon dips after $150M convertible notes offering proposal Seeking Alpha - 2/10/2021 5:43:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/10/2021 4:00:55 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/10/2021 12:26:30 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/10/2021 11:19:26 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/29/2021 5:28:25 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/14/2021 4:16:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/12/2021 4:29:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/12/2021 4:28:34 PM
mcp4   Wednesday, 10/17/18 02:22:12 PM
Re: None
Post # of 41 
KD025 just got Breakthrough Therapy Designation from the FDA. Breakthrough Therapy Designation is supposed to speed development and review of a drug used for a serious condition when early results show clinical improvement over existing therapies. Alas, it doesn't seem to do anything for the stock price.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences